journal article·2014-06

New coumarin derivatives as carbonic anhydrase inhibitors

Mert Olgun Karataş, Bülent Alici, Ümit Çakir, Engin Çetinkaya, Dudu Demir, Adem Ergün, Nahit Gençer, Oktay Arslan

Publisher page

Abstract

In the current study, a series of 4-chloromethyl-7-hydroxy-coumarin derivatives containing imidazolium, benzimidazolium, bisbenzimidazolium and quaternary ammonium salts were synthesized, characterized and the inhibition effects of the derivatives on human carbonic anhydrases (hCA I and hCA II) were investigated as in vitro. Structures of these coumarins were confirmed by FT-IR, (1)H NMR, (13)C NMR and LC-MS analyses. Structure activity relationship study showed that 3d (IC50: 79 μM for hCA I and 88 μM for hCA II) performed higher inhibitory activity than others.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Enzyme function and inhibition · Chemical Reactions and Mechanisms · Synthesis and Catalytic Reactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Anand P · Bioorg Med Chem · 2012 · 20 · 117510.1016/j.bmc.2011.12.042 ↗
2. Arslan O · Turk J Med Sci · 1996 · 26 · 16310.55730/1300-0144.5146 ↗
3. Arslan M · J Enzyme Inhib and Med Chem · 2012 · 27 · 72210.3109/14756366.2011.611135 ↗
4. Ashida M · Proc Natl Acad Sci USA · 1995 · 92 · 1069810.1073/pnas.92.23.10698 ↗
5. Aydemir T · Artif Cells Blood Substit Immobil Biotechnol · 2009 · 37 · 9210.1080/10731190902742489 ↗
6. Bayram T · J Enzyme Inhib Med Chem · 2007 · 22 · 73910.1080/14756360601114312 ↗
7. Borras J · Bioorg Med Chem · 1999 · 7 · 239710.1016/S0968-0896(99)00190-X ↗
8. 10.3109/10731199.2012.67894310.3109/10731199.2012.678943 ↗
9. Carta F · Bioorg & Med Chem · 2012 · 20 · 226610.1016/j.bmc.2012.02.014 ↗
10. Cicek B · J Chem · 2012 · 24 · 3729
11. Demirel LA · Artif Cells Blood Substit Immobil Biotechnol · 2004 · 32 · 60910.1081/BIO-200039654 ↗
12. Demir D · Artif Cells Blood Substit Immobil Biotechnol · 2012 · 40 · 36910.3109/10731199.2012.696060 ↗
13. 10.1080/1475636090278442510.1080/14756360902784425 ↗
14. Gencer N · Fresen Envir Bull · 2011 · 20 · 590
15. Gencer N · Fresen Environ Bull · 2012 · 21 · 549
16. Gencer N · J Enzyme Inhib and Medicinal Chem · 2012 · 27 · 20810.3109/14756366.2011.584535 ↗
17. Gokce B · J Enzyme Inhib Med Chem · 2012 · 27 · 3710.3109/14756366.2011.574130 ↗
18. Gumus A · J Heteroc Chem · 2010 · 47 · 112710.1002/jhet.435 ↗
19. Gupta SP · J Enzyme Inhib Med Chem · 2005 · 20 · 25110.1080/14756360500067439 ↗
20. Hindi KM · Chem Rev · 2009 · 109 · 385910.1021/cr800500u ↗
21. 10.3109/14756366.2012.67783810.3109/14756366.2012.677838 ↗
22. Khan KM · Bioorg Med Chem · 2012 · 20 · 152110.1016/j.bmc.2011.12.041 ↗
23. 10.1074/jbc.M30898420010.1074/jbc.M308984200 ↗
24. Maren TH · J Pharm Exp Ther · 1960 · 130 · 2629
25. Maresca A · J Am Chem Soc · 2009 · 131 · 305710.1021/ja809683v ↗
26. 10.1021/jm901287j10.1021/jm901287j ↗
27. McKiernan JM · Cancer Res · 1997 · 57 · 2362
28. Nair SK · J Am Chem Soc · 1994 · 116 · 365910.1021/ja00087a086 ↗
29. Nishimori I. 2004. Acatalytic CAs: carbonic anhydrase-related proteins. In: Supuran CT, Scozzafava A, Conway J, Eds. Carbonic Anhydrase—Its Inhibitors and Activators. Boca Raton (FL) USA: CRC Press, pp. 25–43.10.1201/9780203475300.ch2 ↗
30. 10.1021/jm050483n10.1021/jm050483n ↗
31. Nishimori I · Bioorg Med Chem Lett · 2005 · 15 · 382810.1016/j.bmcl.2005.06.055 ↗
32. Nishimori I · Bioorg Med Chem · 2007 · 15 · 722910.1016/j.bmc.2007.08.037 ↗
33. Nishimori I · J Med Chem · 2007 · 50 · 38110.1021/jm0612057 ↗
34. Ozdemir I · J Molec Catal · 2005 · 234 · 18110.1016/j.molcata.2005.02.031 ↗
35. Pastorekova S · J Enzyme Inhib Med Chem · 2004 · 19 · 19910.1080/14756360410001689540 ↗
36. Sayin D · J Enzyme Inhib Med Chem · 2012 · 27 · 59510.3109/14756366.2011.604320 ↗
37. 10.1517/13543776.16.12.162710.1517/13543776.16.12.1627 ↗
38. Smith KS · FEMS Microbiol Rev · 2000 · 24 · 33510.1111/j.1574-6976.2000.tb00546.x ↗
39. Sonmez F · Bioorg Med Chem Lett · 2011 · 21 · 747910.1016/j.bmcl.2011.09.130 ↗
40. Supuran CT · Nat Rev Drug Discov · 2008 · 7 · 16810.1038/nrd2467 ↗
41. 10.1016/j.bmcl.2010.05.00910.1016/j.bmcl.2010.05.009 ↗
42. Supuran CT · Med Res Rev · 2003 · 23 · 14610.1002/med.10025 ↗
43. 10.1021/jm901524f10.1021/jm901524f ↗
44. 10.1016/j.tips.2006.09.00210.1016/j.tips.2006.09.002 ↗
45. Tischer M · Chem Med Chem · 2012 · 7 · 2210.1002/cmdc.201100404 ↗
46. Vullo D · Bioorg Med Chem Lett · 2003 · 13 · 100510.1016/S0960-894X(03)00091-X ↗
47. 10.1021/jm031057+10.1021/jm031057+ ↗
48. Vullo D · Bioorg Med Chem Lett · 2005 · 15 · 97110.1016/j.bmcl.2004.12.052 ↗
49. 10.1016/j.bmcl.2004.12.05310.1016/j.bmcl.2004.12.053 ↗
50. 10.1177/108705710831573910.1177/1087057108315739 ↗